In tumor metastases, the mammalian target of rapamycin (mTOR) signaling pathway plays an important role and mTOR inhibitors have been clinically employed for the treatment of some metastatic tumors [5–8]. The gene discussed is MTOR; the disease is metastatic neoplasm.